weight loss / Weight Loss Tablets
Orlistat
Weight-loss tablet support for orlistat with eligibility and practical use guidance reviewed before supply.
Service-specific pricingClinical review includedOnline questionnairePharmacist-backed fulfilment
Online care request
Start a guided request for Orlistat
The public reference journey starts with a short treatment questionnaire, captures the preferred option, then routes the answers for review before supply is released. This version keeps that structure while rewriting the wording.
Choose the treatment route
Capture the option the person hopes to receive and whether this is a new request or a repeat journey.
A reviewer can still recommend a safer or more suitable alternative.
Complete the required fields in this section before moving forward.
Why request this service online
Tablet-based weight-loss route
Orlistat is often considered by people who want a non-injectable medical weight-loss option.
Practical lifestyle guidance
The treatment works best when combined with dietary changes, so the service can help set realistic expectations.
Online screening before supply
Suitability can be reviewed remotely before treatment is dispensed.
How it works
Complete a short assessment
Answer questions on weight history, current health, and other medicines you use.
Clinical review
A clinician checks whether orlistat is appropriate and whether a different route may suit you better.
Receive approved treatment
If suitable, treatment can move to fulfilment with use guidance included.
About this treatment or service
Orlistat is a tablet-based weight-loss treatment used alongside dietary change. It is generally considered for patients who meet the clinical criteria for medical weight management and prefer an oral route.
Delivery options
Home delivery
Approved treatment can be sent directly in discreet packaging.
Repeat-friendly support
Where appropriate, ongoing treatment can be managed with simpler repeat ordering.
Treatment details
The clinical review usually checks BMI, gastrointestinal conditions, current medicines, and whether treatment expectations and diet-related advice are understood before supply is approved.